Critical Care Pharmacist Attitudes and Perceptions of Neuromuscular Blocker Infusions in ARDS

Critical Care Pharmacist Attitudes and Perceptions of Neuromuscular Blocker Infusions in ARDS

Background: Current critical care pharmacist (CCP) practices and perceptions related to neuromuscular infusion (NMBI) use for acute respiratory distress syndrome (ARDS) maybe different with the COVID-19 pandemic and the publication of 2020 NMBI practice guidelines. Objective: To evaluate CCP practic...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Annals of pharmacotherapy 2023-11, Vol.57 (11), p.1282-1290
Hauptverfasser: Devlin, John W., Train, Sarah E., Burns, Karen E. A., Massaro, Anthony, Wu, Ting Ting, Castor, Timothy, Vassaur, John, Selvan, Kavitha, Kress, John P., Erstad, Brian L.
Format: Artikel
Sprache:eng
Schlagworte:
Adult
COVID-19
Critical Care
Humans
Neuromuscular Blocking Agents - therapeutic use
Pandemics
Pharmacists
Respiration, Artificial
Respiratory Distress Syndrome - drug therapy
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background: Current critical care pharmacist (CCP) practices and perceptions related to neuromuscular infusion (NMBI) use for acute respiratory distress syndrome (ARDS) maybe different with the COVID-19 pandemic and the publication of 2020 NMBI practice guidelines. Objective: To evaluate CCP practices and perceptions regarding NMBI use for patients with moderate-severe ARDS. Methods: We developed, tested, and electronically administered a questionnaire (7 parent-, 42 sub-questions) to 409 American College of Clinical Pharmacy (ACCP) Critical Care Practice and Research Network members in 12 geographically diverse states. The questionnaire focused on adults with moderate-severe ARDS (PaO2:FiO2
ISSN:1060-0280
1542-6270
DOI:10.1177/10600280231160437